Literature DB >> 22180428

The role of endocytic pathways in cellular uptake of plasma non-transferrin iron.

Yang-Sung Sohn1, Hussam Ghoti, William Breuer, Eliezer Rachmilewitz, Samah Attar, Guenter Weiss, Z Ioav Cabantchik.   

Abstract

BACKGROUND: In transfusional siderosis, the iron binding capacity of plasma transferrin is often surpassed, with concomitant generation of non-transferrin-bound iron. Although implicated in tissue siderosis, non-transferrin-bound iron modes of cell ingress remain undefined, largely because of its variable composition and association with macromolecules. Using fluorescent tracing of labile iron in endosomal vesicles and cytosol, we examined the hypothesis that non-transferrin-bound iron fractions detected in iron overloaded patients enter cells via bulk endocytosis. DESIGN AND METHODS: Fluorescence microscopy and flow cytometry served as analytical tools for tracing non-transferrin-bound iron entry into endosomes with the redox-reactive macromolecular probe Oxyburst-Green and into the cytosol with cell-laden calcein green and calcein blue. Non-transferrin-bound iron-containing media were from sera of polytransfused thalassemia major patients and model iron substances detected in thalassemia major sera; cell models were cultured macrophages, and cardiac myoblasts and myocytes.
RESULTS: Exposure of cells to ferric citrate together with albumin, or to non-transferrin-bound iron-containing sera from thalassemia major patients caused an increase in labile iron content of endosomes and cytosol in macrophages and cardiac cells. This increase was more striking in macrophages, but in both cell types was largely reduced by co-exposure to non-transferrin-bound iron-containing media with non-penetrating iron chelators or apo-transferrin, or by treatment with inhibitors of endocytosis. Endosomal iron accumulation traced with calcein-green was proportional to input non-transferrin-bound iron levels (r(2) = 0.61) and also preventable by pre-chelation.
CONCLUSIONS: Our studies indicate that macromolecule-associated non-transferrin-bound iron can initially gain access into various cells via endocytic pathways, followed by iron translocation to the cytosol. Endocytic uptake of plasma non-transferrin-bound iron is a possible mechanism that can contribute to iron loading of cell types engaged in bulk/adsorptive endocytosis, highlighting the importance of its prevention by iron chelation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180428      PMCID: PMC3342967          DOI: 10.3324/haematol.2011.054858

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  36 in total

1.  Lipopolysaccharide internalization activates endotoxin-dependent signal transduction in cardiomyocytes.

Authors:  D B Cowan; S Noria; C Stamm; L M Garcia; D N Poutias; P J del Nido; F X McGowan
Journal:  Circ Res       Date:  2001-03-16       Impact factor: 17.367

Review 2.  Nature of nontransferrin-bound iron.

Authors:  Robert C Hider
Journal:  Eur J Clin Invest       Date:  2002-03       Impact factor: 4.686

3.  Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells.

Authors:  O Kakhlon; Y Gruenbaum; Z I Cabantchik
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

Review 4.  The importance of non-transferrin bound iron in disorders of iron metabolism.

Authors:  W Breuer; C Hershko; Z I Cabantchik
Journal:  Transfus Sci       Date:  2000-12

5.  Membrane routing during exocytosis and endocytosis in neuroendocrine neurones and endocrine cells: use of colloidal gold particles and immunocytochemical discrimination of membrane compartments.

Authors:  D V Pow; J F Morris
Journal:  Cell Tissue Res       Date:  1991-05       Impact factor: 5.249

6.  HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte.

Authors:  W C Claycomb; N A Lanson; B S Stallworth; D B Egeland; J B Delcarpio; A Bahinski; N J Izzo
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

7.  Fluorescence analysis of the labile iron pool of mammalian cells.

Authors:  S Epsztejn; O Kakhlon; H Glickstein; W Breuer; I Cabantchik
Journal:  Anal Biochem       Date:  1997-05-15       Impact factor: 3.365

8.  Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants.

Authors:  M A Livrea; L Tesoriere; A M Pintaudi; A Calabrese; A Maggio; H J Freisleben; D D'Arpa; R D'Anna; A Bongiorno
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

9.  Interaction of serum albumin with the Fe(III)-citrate complex.

Authors:  R A Løvstad
Journal:  Int J Biochem       Date:  1993-07

Review 10.  Iron overload cardiomyopathies: new insights into an old disease.

Authors:  P Liu; N Olivieri
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

View more
  24 in total

1.  A decisional algorithm to start iron chelation in patients with beta thalassemia.

Authors:  Fabrice Danjou; Zvi Ioav Cabantchik; Raffaella Origa; Paolo Moi; Michela Marcias; Susanna Barella; Elisabetta Defraia; Carlo Dessì; Maria Loreta Foschini; Nicolina Giagu; Giovan Battista Leoni; Maddalena Morittu; Renzo Galanello
Journal:  Haematologica       Date:  2014-03       Impact factor: 9.941

2.  Evaluation of tumorigenic potential of CeO2 and Fe2O3 engineered nanoparticles by a human cell in vitro screening model.

Authors:  Todd A Stueckle; Donna C Davidson; Raymond Derk; Tiffany G Kornberg; Diane Schwegler-Berry; Sandra V Pirela; Glen Deloid; Philip Demokritou; Sudjit Luanpitpong; Yon Rojanasakul; Liying Wang
Journal:  NanoImpact       Date:  2016-11-22

3.  Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals.

Authors:  Anthony S Grillo; Anna M SantaMaria; Martin D Kafina; Alexander G Cioffi; Nicholas C Huston; Murui Han; Young Ah Seo; Yvette Y Yien; Christopher Nardone; Archita V Menon; James Fan; Dillon C Svoboda; Jacob B Anderson; John D Hong; Bruno G Nicolau; Kiran Subedi; Andrew A Gewirth; Marianne Wessling-Resnick; Jonghan Kim; Barry H Paw; Martin D Burke
Journal:  Science       Date:  2017-05-12       Impact factor: 47.728

4.  Prion protein functions as a ferrireductase partner for ZIP14 and DMT1.

Authors:  Ajai K Tripathi; Swati Haldar; Juan Qian; Amber Beserra; Srinivas Suda; Ajay Singh; Ulrich Hopfer; Shu G Chen; Michael D Garrick; Jerrold R Turner; Mitchell D Knutson; Neena Singh
Journal:  Free Radic Biol Med       Date:  2015-04-08       Impact factor: 7.376

Review 5.  Pathological Roles of Iron in Cardiovascular Disease.

Authors:  Motoi Kobayashi; Tomohiro Suhara; Yuichi Baba; Nicholas K Kawasaki; Jason K Higa; Takashi Matsui
Journal:  Curr Drug Targets       Date:  2018       Impact factor: 3.465

6.  Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation.

Authors:  Anthony Drecourt; Joël Babdor; Michael Dussiot; Floriane Petit; Nicolas Goudin; Meriem Garfa-Traoré; Florence Habarou; Christine Bole-Feysot; Patrick Nitschké; Chris Ottolenghi; Metodi D Metodiev; Valérie Serre; Isabelle Desguerre; Nathalie Boddaert; Olivier Hermine; Arnold Munnich; Agnès Rötig
Journal:  Am J Hum Genet       Date:  2018-02-01       Impact factor: 11.025

Review 7.  Estimating tissue iron burden: current status and future prospects.

Authors:  John C Wood
Journal:  Br J Haematol       Date:  2015-03-12       Impact factor: 6.998

8.  ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders.

Authors:  Hyeyoung Nam; Chia-Yu Wang; Lin Zhang; Wei Zhang; Shintaro Hojyo; Toshiyuki Fukada; Mitchell D Knutson
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

Review 9.  Physiology of iron metabolism.

Authors:  Sophie Waldvogel-Abramowski; Gérard Waeber; Christoph Gassner; Andreas Buser; Beat M Frey; Bernard Favrat; Jean-Daniel Tissot
Journal:  Transfus Med Hemother       Date:  2014-05-12       Impact factor: 3.747

10.  Hepatocyte divalent metal-ion transporter-1 is dispensable for hepatic iron accumulation and non-transferrin-bound iron uptake in mice.

Authors:  Chia-Yu Wang; Mitchell D Knutson
Journal:  Hepatology       Date:  2013-07-01       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.